NCT00003796View on ClinicalTrials.gov

Irofulven in Treating Patients With Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

May 31, 1999

Primary Completion Date

December 31, 2003

Conditions

Breast Cancer

Interventions

DRUG

irofulven

Trial Locations (1)

78229-3900

University of Texas Health Science Center at San Antonio, San Antonio

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH